Overview

Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Status:
Completed

Trial end date:
2007-04-01

Target enrollment:

Participant gender:

Summary

To determine whether the extent of the ischemic penumbra apparent on perfusion-diffusion MRI can be used to identify patients who would respond positively and safely to tissue plasminogen activator (tPA) beyond 3 hours post-stroke.

Phase:

Phase 2

Details

Lead Sponsor:

Melbourne Health

Collaborator:

Boehringer Ingelheim

Treatments:

Tissue Plasminogen Activator